Background: Antibiotic use can have negative unintended consequences including disruption of the human microbiota, which is thought to protect against pathogen overgrowth. We conducted a systematic review to assess whether there is an association between exposure to antibiotics and subsequent risk of communityacquired infections.
Introduction
Antibiotics are an important weapon in our fight against bacterial infections. Antibiotic use is associated with recognized harms, including the emergence of antibiotic-resistant organisms. 1 There is concern that straightforward infections that are currently easy to control may become untreatable in the future. The growing threat of antimicrobial resistance has been declared a global public health crisis. 2 Much attention has been focused on limiting inappropriate antibiotic usage as a strategy to control drug resistance, particularly in primary care, where 90% of antibiotic prescriptions are issued. 1 Even so, in the UK, most general practices continue to prescribe antibiotics at rates in excess of what is clinically justified. 3 Antibiotic therapy can have further unintended consequences, other than selection of resistant microorganisms. The human microbiota is a complex community of up to a hundred trillion microorganisms lining the epithelial surfaces of their hosts and that are exposed to the outside world. 4 The microbiota influences human health through its role in a diverse range of physiological functions, 4 including a protective role in defence against pathogens. The microbiota is thought to contribute to development of the host's immune system and its response to infection. 5 The huge range of organisms in the microbiota, commensals and potential pathogens, compete with each other for attachment sites and nutrients, thereby preventing pathogen overgrowth. 6 Exposure to antibiotics can change the composition of the microbiota, reducing microbial diversity and allowing the overgrowth of potentially V C The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com. harmful microorganisms. 6 Short-term antibiotic treatment for Helicobacter pylori eradication, for example, reduces microbial diversity in the human throat and gut microbiota, which in some cases persists for up to 4 years. 7 The question arises whether antibiotics prescribed to treat an acute bacterial infection could paradoxically predispose individuals to future infections due to collateral damage inflicted on the microbiota. Clostridium difficile-associated diarrhoea is a well-recognized example of an infection resulting from pathogenic colonization of a microbial community disrupted by recent antibiotic use. 8, 9 Antibiotic treatment is also associated with increased risk of fungal infection. [10] [11] [12] Are there other mediumand long-term infection risks associated with antibiotic use unrelated to increased resistance, or infection with C. difficile or opportunist fungi? This systematic review sought evidence of the association between antibiotic use and subsequent risk of infection in the community setting, unrelated to these previously known infection risks.
Objectives
To examine whether exposure to antibiotic therapy is associated with subsequent increased risk of community-acquired infections.
Methods
Procedures used in this review were consistent with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. 13 
Protocol and registration
A review protocol was submitted in advance to PROSPERO, which is a database of systematic review protocols (registration ID: CRD42016048521). 14 
Eligibility criteria
Our inclusion criteria were: (i) studies, of any design, evaluating the risk of community-acquired infection associated with prior antibiotic usage; (ii) human participants, of any age, in the community setting; (iii) studies that assessed risk of infection associated with prior antibiotic exposure compared with the risk of infection without prior antibiotic exposure, in the same period; and (iv) an endpoint of any community-acquired infection. Our exclusion criteria were: (i) studies focused on immune-compromised patient groups (e.g. patients with human immunodeficiency virus) as these would not be representative of the general population; (ii) studies focusing on infections that are known to be associated with prior antibiotic exposure including fungal infection [10] [11] [12] and C. difficile infection; 9 (iii) studies focusing exclusively on infections caused by antibiotic-resistant organisms as these have been the subject of a previous systematic review 15 (furthermore, these studies would not provide a true estimate of the overall risk of infection following antibiotic exposure because infections resulting from nonresistant organisms would be excluded); (iv) studies assessing the risk of nosocomial infections because their relationship with prior antibiotic use could be confounded by other factors (e.g. vulnerable patients, infectious contacts, invasive procedures); (v) non-English language articles; (vi) reviews, letters, editorials and case reports; (vii) studies assessing the impact of prior antibiotic use on complications resulting from a specific infection (e.g. mortality rate); and (viii) studies examining the use of antibiotics as a prophylactic measure to prevent a specific infection (e.g. post-operative wound infection) because such studies are not designed to assess the impact of antibiotic exposure on the subsequent risk of acquiring other unrelated infections.
Search strategy
The initial literature search was performed on 29 April 2016. The search was repeated on 30 June 2017 to identify further articles published since the date of the initial search. The databases searched were MEDLINE, EMBASE and Web of Science. No restrictions were imposed on the publication period. Search terms included both text words and MESH terms. Detailed search strategies are presented in Table S1 (available as Supplementary data at JAC Online). The reference lists of eligible studies and review articles were screened to identify further studies eligible for inclusion.
Study selection
Covidence software was used to facilitate the screening and selection of studies. 16 The first reviewer (U. M.) conducted the literature search, removed duplicate articles, and screened titles and abstracts with respect to the eligibility criteria. Full-text articles of potentially relevant studies were independently assessed for eligibility by two reviewers (U. M. and P. W.). Any disagreements were resolved through discussion and consensus.
Data extraction
One reviewer (U. M.) extracted data from the full texts of included studies. Extracted data were summarized in a predesigned format and crosschecked by a second reviewer (P. W.). Disagreements were resolved through discussion and consensus.
Data collected included the first author, publication year, country of study, study design, study objectives, participant characteristics, exposure definition (i.e. antibiotic class, length of treatment, time from exposure to infection), exposure interval (length of time prior to the infection during which antibiotic exposure was assessed), exposure ascertainment method, infection type, definition of cases and the comparison group, sample size, main outcome measure and confounding variables. The primary outcome of interest was the OR for the association of infection with prior antibiotic exposure.
Quality assessment
The Newcastle Ottawa Scale (NOS), a tool for assessing the quality of nonrandomized studies, 17 was applied independently to each study by two reviewers (U. M. and P. W.). Any disagreements were resolved through discussion and consensus.
Each study could be assigned a maximum of nine points; four for the selection domain, two for the comparability domain and three for the exposure domain. Studies assigned NOS scores of 7 were considered high quality, 5-6 were considered moderate quality and ,5 were considered low quality.
Data synthesis and analysis
Our research question is broad, aiming to examine the association between past antibiotic consumption and a diverse range of infections, at different body sites, caused by a variety of different microorganisms. Quantitative pooling of results through a meta-analysis was not justified owing to the high degree of clinical heterogeneity expected between studies in terms of the infection types being investigated and differences in antibiotic exposures. Any observed association between antibiotic use and subsequent infection was considered unlikely to be universal for all infection types. We have therefore reported the findings of the systematic review as a narrative (descriptive) synthesis.
Results

Study selection
The literature search retrieved 22582 publications. Six additional publications were identified from the reference list of retrieved Systematic review articles. After adjusting for duplicates, 21439 publications remained. After screening by title and abstract, 21053 publications were excluded. A full-text review was conducted of 386 publications, from which 18 met the eligibility criteria and were included in the review. [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] The detailed rationale behind the exclusion of studies is presented in Figure 1 . Tables 1 and 2 summarize the main characteristics of the included studies. Sixteen studies were case-control studies and two were cohort studies.
Study design and participant characteristics
The studies involved a total of 349085 participants. Study sample sizes ranged from 105 24 to 164461 34 participants. In 13 studies the hypothesis that antibiotic use would increase subsequent risk of infections was not stated [19] [20] [21] [22] 24, [26] [27] [28] 30, [32] [33] [34] [35] and earlier antibiotic use was one of many other variables assessed as potential risk factors for infection.
Exposure assessment and definition
Six studies ascertained exposure status from recorded prescription data. 18, 19, 23, 29, 31, 34 Ten studies determined exposure status through participant interview or questionnaire. [20] [21] [22] [26] [27] [28] 30, 32, 33, 35 One study interviewed both participants and their physician, 24 and in one study medication data was obtained from the physician only when the participant was unsure. 25 Seventeen studies defined exposure as the consumption of any antibiotic medication. One study defined exposure in terms of specific antibiotic classes. 31 In one study the exposure status was defined as an antibiotic prescription of 6 weeks or more for acne. 31 In the remaining Systematic review The OR for UTI is statistically significant; however, the authors of the study concluded that it was not clinically meaningful.
JAC
Systematic review 17 studies, exposure was not defined in terms of the duration of antibiotic course. The length of time during which antibiotic exposure was assessed prior to the infection (exposure interval) was specified in 14 out of 18 studies. [18] [19] [20] [21] [23] [24] [25] [26] [27] [28] [29] [30] 33, 34 In these studies, the exposure interval ranged from 2 weeks to 1 year. The median exposure interval was 2 months.
Case definition
Fourteen studies defined infection on the basis of a positive microbiological specimen. [19] [20] [21] [22] [23] [24] [25] [26] [27] 29, 30, 32, 33, 35 Three studies defined infection on the basis of routinely recorded primary care data. 18, 31, 34 One study on recurrent furunculosis did not specify how the cases were defined. 28 
Comparison group
In case-control studies the control group consisted of participants who did not have a confirmed history of the infection of interest. In the cohort study on patients with acne, risk of infection was compared between those who were prescribed longterm antibiotics for acne, versus those who were not. 31 In the cohort study on risk of recurrent boil and abscess, antibiotic prescription rates were compared amongst participants who had a repeat consultation for a boil or abscess within 12 months, versus those who did not. 34 
Associations between exposure and outcome
Positive and significant associations between prior antibiotic use and subsequent risk of infection were reported in 16 out of 18 studies, including one study on Campylobacter jejuni infection, 26 one study on recurrent furunculosis, 28 one study on invasive Haemophilus influenzae type b infection, 32 one study on infectious mastitis, 35 one study on meningitis, 18 one study on invasive pneumococcal disease, 19 one study on Staphylococcus aureus skin infection, 27 two studies on typhoid fever, 30, 33 one study on recurrent boils and abscesses, 34 one study on upper respiratory tract infection and urinary tract infection 31 and five studies on Salmonella infection. 20, 21, 23, 24, 29 The outcome measure and 95% CI from each study is presented in Tables 1 and 2 .
Salmonella infection
Nine out of 18 studies assessed the association between antibiotic use and subsequent risk of Salmonella infection. [20] [21] [22] [23] [24] [25] 29, 30, 33 As this was the most frequently studied infection the results are described here in further detail. Two out of nine studies focused exclusively on cases of typhoid fever. 30, 33 Both studies reported a positive and statistically significant association between prior antibiotic use and subsequent risk of typhoid fever. The remaining seven studies assessing the risk of Salmonella infection did not restrict the definition of cases to typhoid fever. [20] [21] [22] [23] [24] [25] 29 Five out of seven studies reported a positive and significant association between prior antibiotic use and risk of Salmonella infection. 20, 21, 23, 24, 29 From these five studies, three studies reported 95% CIs for the OR that included 1.0 at the lower end. 20, 21, 23 In these studies the effect was of marginal statistical significance. We found two negative studies, which did not demonstrate a statistically significant association between prior antibiotic use and subsequent risk of Salmonella infection.
22,25
Timing of antibiotic exposure
Four studies assessed the effect of timing of antibiotic exposure on subsequent risk of infection. 18, 19, 23, 29 Increased risk of community-acquired infection after antibiotic exposure was documented up to 1 year in three 18, 23, 29 out of four studies except for one study on pneumococcal disease 19 that showed an increased risk only in the following month.
In the case of meningitis, 18 the association between antibiotic exposure and subsequent infection risk remained statistically significant over the 12 month exposure period prior to the infection, although as the interval between exposure and subsequent infection increased, the effect size generally diminished (0-7 days: OR " 4.23, 95% CI " 3.56-5.04; 8-30 days: OR " 2.12, 95% CI " 1.86-2.42; 31-90 days: OR " 1.88, 95% CI " 1.70-2.08; 91-180 days: OR " 1.74, 95% CI " 1.56-1.94; 181-365 days: OR " 1.93, 95% CI " 1.76-2.13).
The ORs for the association between antibiotic exposure and risk of pneumococcal disease 19 were reported separately for exposures occurring between 0 and 30 days, 31 and 60 days, and 61 and 90 days before the infection and were 1.9 (95% CI " 1.1-3.2), 1.6 (95% CI " 0.89-3.0) and 1.2 (95% CI " 0.60-2.5), respectively.
Gradel et al. 29 reported a higher antibiotic consumption rate amongst cases of Salmonella infection, compared with controls, for a 1 year period prior to infection. The excess antibiotic consumption amongst cases remained constant during the first 30 weeks of the 1 year exposure period, after which it increased steadily until 2 weeks preceding the infection.
In the study by Neal et al. 23 the risk of Salmonella infection was greater for antibiotic exposure in the preceding month (1.8, 0.9-3.8) compared with exposure in the past year (1.4, 1.0-2.1).
Three studies assessed antibiotic exposure in the 12 months preceding infection, but excluded exposure occurring within the previous 7 days to account for the possibility of reverse causation. These studies demonstrated an association between previous antibiotic use and recurrent furunculosis (OR " 16.6, 95% CI " 2.2-66.0), 28 non-typhoid Salmonella (OR " 1.59, 95% CI " 1.43-1.77) 29 and meningitis (OR " 2.04, 95% CI " 1.91-2.18). 18 
Number of antibiotic prescriptions
A dose-response relationship was reported between antibiotic exposure and risk of meningitis. 18 Patients receiving 4 antimicrobials in the preceding 12 months had a higher risk of meningitis (2.85, 2.44-3.34) compared with those receiving one antimicrobial prescription (1.74, 1.62-1.88) .
The association between invasive pneumococcal disease 19 and antibiotic usage in the preceding 3 months was stronger for patients who had 2 antibiotic prescriptions (2.1, 1.2-3.8), compared with those who had a single prescription (1.4, 0.88-2.3).
Quality assessment
Seven studies were deemed to be of high quality, ten studies of moderate quality and one study of low quality (see Tables S2 and S3 ). There was considerable variation between studies in the selection of confounding variables. The most common confounding variables Systematic review JAC were age, gender and location. Case-control studies scored poorly on method of ascertainment of exposure, mostly relying on written self-reports from participants. Non-response rates were also poorly reported in case-control studies.
Discussion
We have found that previous antibiotic use was associated with 12 different community-acquired infections, including infections of viral and bacterial origin. The associated infections ranged from common ailments such as upper respiratory tract infection (URTI) and infectious diarrhoea to relatively rare, but potentially lifethreatening, infections such as meningitis. Our findings provide evidence that harms due to antibiotic use could extend beyond the widely recognized threat of promotion of drug-resistant organisms, to include an increased subsequent risk of infections caused by a range of microorganisms and at many different anatomical sites.
Prior antibiotic consumption and subsequent infection risk was not the primary research question in most of the included studies. Most studies assessed several potential risk factors for infection, and in these the discovery of an association between antibiotic use and subsequent infection was an unexpected finding. The novelty of this finding was not commented upon by many authors. Despite inclusion as a potential risk factor in several studies, the hypothesis that prior antibiotic therapy could increase future risk of community-acquired infection has received little attention in the published literature.
We did not find evidence of an association between prior antibiotic use and subsequent infection in any randomized controlled clinical trials of antibiotics. This was probably for two reasons. Firstly, prior antibiotic use was not an acknowledged confounding factor. Secondly, infections occurring at sites different to the target of the intervention would not have been seen as an adverse effect of the use of antibiotics. Recurrence of the target infection would have been interpreted as intervention failure, not an adverse effect of the intervention.
The association between exposure to antibiotics and future infection may be explained by the disruptive effect of antibiotic therapy on the microbiota. Antibiotic-induced alteration of the microbiota could diminish the local suppressive effect of commensal organisms on pathogen overgrowth. There is evidence that the microbiota stimulates host epithelial cells to produce antimicrobial peptides 36 and promotes antimicrobial activity of local immune cells. 5, 37 Furthermore, the gut microbiota may modulate systemic immunity and influence host susceptibility to infections distant from the gut. 38 Experimental studies have shown that microbiota-depleted mice have reduced production of inflammatory cytokines, decreased bactericidal activity of macrophages, reduced production, extravasation and bactericidal activity of neutrophils and impaired antibody response to viral infections. 38 If alteration of the microbiota was responsible for the increased infection risk following antibiotic therapy it might be expected that the risk of infection would return to baseline as the microbiota recovered to its pretreatment state. Four studies analysed variation in the strength of association between prior antibiotic therapy and subsequent infection in relation to the timing of antibiotic exposure. 18, 19, 23, 29 In three out of four studies there was a trend for weakening of the association between prior antibiotic therapy and subsequent infection as the interval between antibiotic use and diagnosis of infection increased. 18, 19, 29 In the case of pneumococcal disease the observed association between antibiotic exposure and risk of infection weakened to the extent that the association failed to reach statistical significance for distant exposures, i.e. those occurring .30 days prior to the infection. 19 Together these findings support the hypothesis that transient alteration of the microbiota may be responsible for mediating an increased infection risk following antibiotic exposure. One study on Salmonella infection was an exception since it did not demonstrate a weakening of the association between antibiotic exposure and subsequent infection as the interval between antibiotic exposure and diagnosis of infection increased. 23 The risk of meningitis and invasive pneumococcal disease was found to increase with an increasing number of antibiotics to which the patient was exposed prior to the diagnosis of infection. 18, 19 Repeated exposure to antibiotics within the exposure interval would be expected to delay the recovery of the microbiota to its pretreatment state. This further strengthens the suspicion that antibiotic-induced alteration of the microbiota may be responsible for increased infection risk following antibiotic therapy.
On the other hand the observed association between previous antibiotic exposure and subsequent infection could reflect excessive prior antibiotic consumption amongst persons with increased susceptibility to infections that was independent of the effect of antibiotic therapy on the microbiota. This susceptibility to infections could have been inherited or acquired. If this were the case, frequent antibiotic consumption above a specific threshold would be a clinically valuable marker in identifying a subset of patients who warrant further investigation for a previously unrecognized immune vulnerability.
A further explanation for the observed association may lie in the variation between patients of the threshold for seeking a medical consultation for symptoms. Patients with frequent healthcareseeking behaviour may be more likely to be diagnosed with infections, and to be prescribed antibiotics. One study controlled for frequency of medical care in their analysis and found an increased risk of URTI in patients exposed to long-term antibiotics for acne, even after adjusting for consultation frequency. 31 
Limitations and future work
To our knowledge, this is the first systematic review to demonstrate the association between prior antibiotic therapy and subsequent risk of community-acquired infections, other than infections caused by antibiotic-resistant organisms, fungal organisms and C. difficile.
The association between antibiotic use and subsequent risk of infection should be interpreted with caution. The observational nature of the included studies means it is not possible to establish causality. Most studies did not exclude antibiotic exposure occurring in the days leading up to the infection, and hence reverse causation should be considered as an alternative explanation for the observed association. Antibiotic exposure could have occurred as a result of medical consultation due to prodromal symptoms of the later infection being studied, rather than as a distant exposure due to an unrelated illness, which then increased susceptibility to the current infection.
A further limitation is the possibility of confounding by indication resulting from underlying host susceptibility to infection, as Systematic review described earlier. This may be addressed by designing studies that take this into account or adjust for infection susceptibility.
The use of retrospective self-reports of antibiotic exposure in some studies is likely to have introduced recall bias. There was insufficient data on adherence to the prescribed course of antibiotics, which could have resulted in misclassification of exposure status.
Most studies did not include sufficient prescribing details to establish whether there was a dose-response relationship between antibiotic usage and subsequent infection, or whether the relationship was stronger with broad-spectrum antibiotics, a finding that might have provided more support for the hypothesis of collateral microbiota damage.
The studies on Salmonella infection provided inconclusive evidence for whether there was an association between infection and prior antibiotic therapy. This warrants further investigation, possibly through a meta-analysis, which could provide a more precise estimate of the overall effect size.
A further limitation of our review was the exclusion of nonEnglish-language papers and those that met the inclusion criteria but for which the full-text article was irretrievable.
Conclusions
Prior antibiotic therapy was associated with a diverse range of community-acquired infections. This included infections caused by antibiotic-resistant and non-resistant organisms. The association between antibiotic exposure and subsequent infection became weaker with increasing time from antibiotic exposure. The risk of infection increased with increasing number of antibiotics to which the patients were exposed. Whilst antibiotic therapy is often necessary for the treatment of bacterial infections, our findings highlight the continued need to limit inappropriate antibiotic prescriptions in primary care, both to reduce the consequences of bacterial resistance and possibly also to reduce the risk of future infections. The observed association may help clinicians in dissuading their patients from insisting on an antibiotic prescription when this is deemed not to be clinically indicated. New research may help discover whether other infection types, not examined by the studies included in our review, are also associated with prior antibiotic therapy. Further studies are also required to examine the mechanisms underlying the observed association, particularly whether this association could be mediated through antibioticinduced collateral damage to the microbiota.
